Patient and image data management in positron emission tomography-computed tomography for radiation therapy and therapy response assessment

Seminars in Ultrasound, CT and MRI

Volumn 31, Issue 6, 2010, Pages 480-489

  Faasse, Todd ^a   Shreve, Paul ^a,b  

^a PET Medical Imaging Center   (United States)

^b Advanced Radiology Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE;

ABDOMINAL CANCER; ARTICLE; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; EQUIPMENT DESIGN; GLUCOSE METABOLISM; HEAD AND NECK CANCER; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE RECONSTRUCTION; IMAGE RETRIEVAL; LUNG CANCER; PATIENT CARE; PATIENT MONITORING; PATIENT POSITIONING; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS MODEL; QUALITY CONTROL; RADIATION DOSE; RADIOLOGY DEPARTMENT; RESPIRATORY GATED IMAGING; STANDARD; TREATMENT PLANNING; TREATMENT RESPONSE;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; PATIENT POSITIONING; POSITRON-EMISSION TOMOGRAPHY; QUALITY ASSURANCE, HEALTH CARE; RADIOLOGY INFORMATION SYSTEMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RESPIRATORY-GATED IMAGING TECHNIQUES; SAFETY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78649938874     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sult.2010.09.001     Document Type: Article

References (16)

1. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 2003, 57:853-863.
2. Lucignani G., Jereczek-Fossa B.A., Orecchia R. The role of molecular imaging in precision radiation therapy for target definition, treatment planning and optimization and quality control. Eur J Nucl Med Mol Imaging 2004, 31:1059-1063.
3. Faasse T., Shreve P. Positron emission tomography-computed tomography patient management and workflow. Semin Ultrasound CT MRI 2008, 29:277-282.
4. Berson A.M., Emery R., Rodriguez L., et al. Clinical experience using respiratory gated radiation therapy: Comparison of free-breathing and breath-hold techniques. Int J Radiat Oncol Biol Phys 2004, 60:419-426.
5. Shreve P., Swanston N.M., Faasse T. Positron emission tomography-computed tomography protocols for radiation therapy planning and therapy response assessment. Semin Ultrasound CT MRI 2010, 31:468-479.
6. Stevens C.W., Munden R.F., Forster K.M., et al. Respiratory-driven lung motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys 2001, 51:62-68.
7. Bussels B., Goethais L., Feron M., et al. Respiration-induced movement of the upper abdominal organs: A pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol 2003, 68:69-74.
8. D'Souza W.D., Nazareth D.P., Zhang B., et al. The use of gated 4D CT imaging in planning for stereotactic body radiation therapy. Med Dosim 2007, 32:92-101.
9. Blodgett T. Best practices: Consensus on performing positron emission tomography-computed tomography for radiation therapy planning and therapy response assessment. Semin Ultrasound CT MRI 2010, 31:506-515.
10. Kinhan P.E., Fletcher J.W. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MRI 2010, 31:496-505.
11. Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
12. Juweid M.E., Stroobants S., Hoekstra O.S., et al. Use of positron emission tomography for response assessment in lymphoma: Consensus of the Imaging Subcommittee of International Harmonization project in lymphoma. J Clin Oncol 2007, 25:571-578.
13. Shankar L.A., Hoffman J.M., Bacharach S., et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med 2006, 47:1059-1066.
14. Wahl R.L., Jacene H., Kasamon Y., et al. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009, 50:122S-150S.
15. Boellaard R., Oyen W.J., Hoekstra C.J., et al. The Netherlands protocol for standardization and quantification of FDG whole body PET studies in multi-center trials. Eur J Nucl Med Mol Imaging 2008, 35:2320-2333.
16. Büther F., Ernst I., Dawood M., et al. Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography. Eur J Nucl Med Mol Imaging 2010 July 6, (Epub ahead of print).